Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $0.6950 per EA under NDC 47781046813. Its NADAC has been published 496 times since Feb 22, 2017.
FDA first approved this application on Aug 3, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Alvogen Inc.NDC
47781046813
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA202595FDA Approved
8/3/2016
TE Code
AB
On Market Since
12/12/2016
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 496 times since Feb 22, 2017, and over the history we have for it it has declined 92.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6950 per EA |
|---|---|
| All-time high | $8.7338 (May 10, 2017) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $2.2425 |
| Average price | $3.3432 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 496 |
| Tracking since | Feb 22, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Alvogen Inc., is $0.6950 per EA (NDC 47781046813), effective Aug 19, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 92.0%. It has been tracked across 496 weekly CMS publications since Feb 22, 2017.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Feb 22, 2017, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.7338 (May 10, 2017), with a median of $2.2425 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 47781046813) is labeled by Alvogen Inc., and CMS classifies it as a generic product.